To investigate whether CDA‐producing strains can play a role in controlling infection in vivo, we challenged mice nasally with influenza A virus (IAV) after treatment with the relevant strains and evaluated their protective efficacy (Figure 5A). The gene discussed is CDA; the disease is infection.